Clinical Trial: The Safety and Microbial Changes in the Use of Intranasal Neosporin(R): A Prospective Study

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698938) titled 'The Safety and Microbial Changes in the Use of Intranasal Neosporin(R): A Prospective Study' on July 07.

Brief Summary: Neosporin is an over-the-counter, FDA-approved triple-antibiotic ointment. It is widely used to treat and prevent skin infections following minor burns and injuries. Although the Neosporin(R) prospect indicates its use is strictly topical, it is often used intranasally by ear, nose, and throat specialists, plastic surgeons, and intensivists to prevent and treat various conditions. Nonetheless, no literature has documented the safety of intranasal Neosporin(R). We designed a prospective study to assess the safety of...